Assignee
APTEVO RES & DEVELOPMENT LLC
US·9 granted patents·13 pending applications·19 citations·filing 2013–2024
Top patents by PatentIndex Score
22 records- 0190US10239949B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Mar 26, 2019·6 cites·20 claims
- 0288US11939392B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Granted Mar 26, 2024·1 cites·15 claims
- 0388US10676533B2Methods of treatment of CD123 overexpressing disordersAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Jun 9, 2020·4 cites·9 claims
- 0486US11312786B2Oncofetal antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2019·Granted Apr 26, 2022·2 cites·19 claims
- 0583US11242400B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Granted Feb 8, 2022·2 cites·33 claims
- 0682US12441798B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2024·Granted Oct 14, 2025·0 cites·15 claims
- 0774US10202452B2CD3 binding polypeptidesAPTEVO RES & DEVELOPMENT LLC·Filed 2013·Granted Feb 12, 2019·3 cites·33 claims
- 0874US2020354447A1Single-chain multivalent binding proteins with effector functionAPTEVO RES & DEVELOPMENT LLC·Filed 2019·Application pending·0 cites
- 0971US11352426B2CD3 binding polypeptidesAPTEVO RES & DEVELOPMENT LLC·Filed 2016·Granted Jun 7, 2022·1 cites·37 claims
- 1066US2021095046A1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
- 1165US11725060B2Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Aug 15, 2023·0 cites·24 claims
- 1263US2018118823A1Single-chain multivalent binding proteins with effector functionAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 1362US2024262920A1Dosing regimens for protein therapeuticsAPTEVO RES & DEVELOPMENT LLC·Filed 2022·Application pending·0 cites
- 1459US2019290755A1B-cell reduction using cd37-specific and cd20-specific binding moleculesAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Application pending·0 cites
- 1557US2024301086A1Tumor-associated antigens and cd3-binding proteins, related compositions, and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Application pending·0 cites
- 1656US2024150483A1COMPOSITIONS COMPRISING 4-1BB and OX40 BINDING PROTEINS AND METHODS OF USEAPTEVO RES & DEVELOPMENT LLC·Filed 2022·Application pending·0 cites
- 1756US2018273642A1Heterodimer binding proteins and uses thereofAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 1855US2018100021A1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 1950US2022242962A14-1bb and ox40 binding proteins and related compositions and methods, antibodies against 4-1bb, antibodies against ox40APTEVO RES & DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
- 2050US2023303720A1Formulations for protein therapeuticsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Application pending·0 cites
- 2150US2023151102A1Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system componentsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Application pending·0 cites
- 2239US2018022819A1Compositions and methods for combination therapy with prostate-specific membrane antigen binding proteinsAPTEVO RES & DEVELOPMENT LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APTEVO RES & DEVELOPMENT LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →